Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

A Case of Lethal Idiopathic Plasmacytic Lymphadenopathy with Polyclonal Hypergammaglobulinemia: A Medical Challenge for the Forensic Pathologist.

Tattoli L, Solarino B, Schiraldi O, Di Vella G.

J Forensic Sci. 2016 Jul;61(4):1139-1142. doi: 10.1111/1556-4029.13101. Epub 2016 Apr 7.

PMID:
27364300
2.

[Hepatitis C virus infection mimicking hemorrhagic fever: a case report]

Morano CM, Perrone A, Deramo MT, Santarangelo P, Schiraldi O.

Infez Med. 2000;8(4):237-240. Italian.

3.

[Diarrhea as first clinical manifestation of hepatocellular carcinoma].

Giannelli G, Pierri F, Schiraldi O, Antonaci S.

Recenti Prog Med. 2002 Sep;93(9):478-81. Italian.

PMID:
12355985
4.

Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases.

Giannelli G, Pierri F, Trerotoli P, Marinosci F, Serio G, Schiraldi O, Antonaci S.

Hepatol Res. 2002 Sep;24(1):50.

PMID:
12243792
5.

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S.

Am J Pathol. 2002 Jul;161(1):183-93.

6.

Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.

Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S.

Int J Cancer. 2002 Feb 1;97(4):425-31.

7.

Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in chronic hepatitis C: a critical reappraisal.

Antonaci S, Piazzolla G, Napoli N, Vella FS, Fiore G, Schiraldi O.

Microbios. 2001;106(415):203-12. Review.

PMID:
11522131
8.

[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].

Vella FS, Orlando P, Attanasi F, Simone B, Mundo A, Lopalco P, Schiraldi O, Antonaci S.

Recenti Prog Med. 2001 Feb;92(2):107-12. Italian.

PMID:
11294098
9.

[Acute disseminated encephalomyelitis as initial clinical manifestation of common variable immunodeficiency. A case report].

Vella FS, Simone B, Carella A, Schiraldi O, Antonaci S.

Recenti Prog Med. 2000 Jul-Aug;91(7-8):365-7. Italian.

PMID:
10932921
10.

Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.

Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S.

Cytokine. 2000 Jun;12(6):811-4.

PMID:
10843770
11.
12.

Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.

De Mitrio V, Marino R, Cicinelli E, Galantino P, Di Bari L, Giannoccaro F, De Pergola G, Lapecorella M, Schonauer S, Schiraldi O.

Blood Coagul Fibrinolysis. 2000 Mar;11(2):175-82.

PMID:
10759011
13.

sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology.

Tortorella C, Sacco R, Orlando P, Salerno MT, Schiraldi O, Antonaci S.

Immunopharmacol Immunotoxicol. 2000 Feb;22(1):19-33.

PMID:
10737254
14.

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.

De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.

Blood Coagul Fibrinolysis. 1999 Oct;10(7):409-16.

PMID:
10695766
15.
16.

Soluble HLA class I antigens in chronic hepatitis C: a disease-associated manifestation or molecules modulating immunoresponsiveness?

Antonaci S, Jirillo E, Schiraldi O.

Immunopharmacol Immunotoxicol. 1999 Nov;21(4):727-38. Review.

PMID:
10584208
17.

[Pericardial involvement as initial manifestation of multiple myeloma].

Vella FS, Mongelli M, Grande M, Schiraldi O.

Recenti Prog Med. 1999 Jul-Aug;90(7-8):394-5. Italian.

PMID:
10429520
18.

Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities.

Fiore G, Piazzolla G, Galetta V, Caccetta L, Schiraldi O, Antonaci S.

Microbios. 1999;97(386):29-38.

PMID:
10413866
19.

Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous thrombosis?

De Mitrio V, Marino R, Rendina M, Di Bari L, Francavilla A, Schiraldi O.

Blood Coagul Fibrinolysis. 1999 Jun;10(4):211-2. No abstract available.

PMID:
10390121
20.

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.

Scaraggi FA, De Mitrio V, Marino R, Speciale V, Di Bari L, Petronelli M, Schiraldi O.

Blood Coagul Fibrinolysis. 1999 Jan;10(1):33-8.

PMID:
10070833
22.

Immunoresponsiveness in chronic hepatitis C patients: correlation between tissue and serum findings.

Piazzolla G, Tortorella C, Fiore G, Serrone M, Caccetta L, Jirillo E, Schiraldi O, Antonaci S.

Immunopharmacol Immunotoxicol. 1998 Aug;20(3):337-54.

PMID:
9736440
23.

[Enterococcal endocarditis: clinical features and therapeutic approach].

Perrone A, Guida G, Morano CM, Papa L, Schiraldi O.

Recenti Prog Med. 1997 Nov;88(11):507-12. Italian.

PMID:
9446153
24.

The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease.

Sacco R, Randone A, Flichman D, Oliveri F, Colombatto P, Scaraggi FA, Bonino F, Schiraldi O, Brunetto MR.

Clin Diagn Virol. 1997 Nov;8(3):189-94.

PMID:
9406648
25.

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V.

Science. 1997 Jul 11;277(5323):225-8.

26.

In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.

Fiore G, Angarano I, Caccetta L, Serrone M, Jirillo E, Schiraldi O, Antonaci S.

Eur J Gastroenterol Hepatol. 1997 May;9(5):491-6.

PMID:
9187883
27.

CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C.

Fiore G, Galetta V, Piazzolla G, Angarano I, Jirillo E, Schiraldi O, Antonaci S.

Microbios. 1997;92(371):73-82.

PMID:
9589606
28.

Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship?

Ranieri VM, Dell'Erba A, Gentile A, Bruno F, La Gioia V, Spagnolo A, Sacco R, Caruso G, Antonaci S, Schiraldi O, Brienza A.

Intensive Care Med. 1997 Jan;23(1):119-21.

PMID:
9037652
29.

Effects of interferon-alpha treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C.

Piazzolla G, Giannelli G, Antonelli G, Tortorella C, Jirillo E, Schiraldi O, Antonaci S.

Immunopharmacol Immunotoxicol. 1996 Nov;18(4):529-48.

PMID:
8933168
30.

Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study.

Coppola S, Buccoliero G, Laddago V, Monno L, Perrone A, Guida G, Schiraldi O, Angarano G.

New Microbiol. 1996 Oct;19(4):351-5.

PMID:
8914137
31.

Hepatitis C virus infection. Biological and immunological features.

Fiore G, Jirillo E, Schiraldi O, Antonaci S.

Recenti Prog Med. 1996 Jun;87(6):301-7. Review.

PMID:
8766958
32.

Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B.

Giannelli G, Brassard J, Foti C, Stetler-Stevenson WG, Falk-Marzillier J, Zambonin-Zallone A, Schiraldi O, Quaranta V.

Lab Invest. 1996 Jun;74(6):1091-104.

PMID:
8667613
33.

Liver steatosis and chronic hepatitis C: a spurious association?

Fiore G, Fera G, Napoli N, Vella F, Schiraldi O.

Eur J Gastroenterol Hepatol. 1996 Feb;8(2):125-9.

PMID:
8723415
34.

[Cutaneous vasculitis, mixed cryoglobulinemia in a patient with non-secreting monolateral pheochromocytoma. A likely paraneoplastic syndrome].

Perrone A, Guida G, Leuci D, Schiraldi O.

Recenti Prog Med. 1995 Dec;86(12):499-502. Italian.

PMID:
8588083
35.

[Glutathione in the treatment of chronic fatty liver diseases].

Dentico P, Volpe A, Buongiorno R, Grattagliano I, Altomare E, Tantimonaco G, Scotto G, Sacco R, Schiraldi O.

Recenti Prog Med. 1995 Jul-Aug;86(7-8):290-3. Italian.

PMID:
7569285
36.

Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.

Giannelli G, Antonelli G, Fera G, Del Vecchio S, Riva E, Broccia C, Schiraldi O, Dianzani F.

Clin Exp Immunol. 1994 Jul;97(1):4-9.

37.

Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors.

Giannelli G, Savoia P, Schiraldi O, Lospalluti M, De Luca M, Marchisio PC, Quaranta V.

Hepatology. 1994 Jul;20(1 Pt 1):56-65.

PMID:
8020905
38.

Monoclonal expansion of immunoglobulin not-secreting CD5+ CD11c+ CD38+ B-cells in a rare case of chronic lymphoplasmacytoid leukaemia.

Grande M, Lucivero G, Gambatesa V, Schiraldi O, Bonomo L.

Nouv Rev Fr Hematol. 1994 Jun;36(3):235-40.

PMID:
7971244
39.

Intrafamilial and sexual transmission of hepatitis C virus.

Scaraggi FA, Lomuscio S, Perricci A, De Mitrio V, Napoli N, Schíraldi O.

Lancet. 1993 Nov 20;342(8882):1300-2. No abstract available.

PMID:
7901603
40.

Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C.

Napoli N, Fiore G, Vella F, Fera G, Schiraldi O.

Eur J Epidemiol. 1993 Nov;9(6):629-32.

PMID:
7512051
41.
42.

2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.

Giannelli G, Antonelli G, Fera G, Dianzani F, Schiraldi O.

J Interferon Res. 1993 Feb;13(1):57-60.

PMID:
8454912
43.

Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS gene-encoded proteins.

Napoli N, Fiore G, Fera G, Modugno A, Giannelli G, Manghisi OG, Schiraldi O.

Digestion. 1993;54(1):9-14.

PMID:
8513991
44.

Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.

Dentico P, Volpe A, Buongiorno R, Fiore G, Carbone M, Manno C, Pastore G, Schiraldi O.

Ital J Gastroenterol. 1993 Jan;25(1):19-22.

PMID:
7679012
45.

Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults.

Dentico P, Buongiorno R, Volpe A, Zavoianni A, Pastore G, Schiraldi O.

Eur J Epidemiol. 1992 Sep;8(5):650-5.

PMID:
1426164
46.

Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.

Dentico P, Buongiorno R, Volpe A, Carlone A, Carbone M, Manno C, Proscia F, Pastore G, Schiraldi O.

Clin Nephrol. 1992 Jul;38(1):49-52.

PMID:
1499169
47.

Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs.

Scaraggi FA, Perricci A, Petronelli M, Lomuscio S, De Mitrio V, Schiraldi O.

Lancet. 1992 Jun 13;339(8807):1486-7. No abstract available.

PMID:
1351168
48.

Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity.

De Pergola G, De Mitrio V, Perricci A, Cignarelli M, Garruti G, Lomuscio S, Ferri G, Schiraldi O, Giorgino R.

Metabolism. 1992 Feb;41(2):131-4.

PMID:
1736034
49.

Prolonged viral hepatitis type A with cholestasis: case report.

Schiraldi O, Modugno A, Miglietta A, Fera G.

Ital J Gastroenterol. 1991 Jul-Aug;23(6):364-6.

PMID:
1742530
50.

Hepatitis B virus infection in hospital staff: epidemiology and persistence of vaccine-induced antibodies.

Dentico P, Zavoianni A, Volpe A, Buongiorno R, Palma R, Calasso A, Pastore G, Schiraldi O.

Vaccine. 1991 Jun;9(6):438-42.

PMID:
1832256

Supplemental Content

Loading ...
Support Center